Breaking News

Landmark Bio Appoints Two New Leaders to Executive Team

Welcomes Gregg Nyberg as chief technology officer and Michael Covington as chief quality and regulatory officer.

Author Image

By: Charlie Sternberg

Associate Editor

Landmark Bio, a collective endeavor launched to accelerate development and industrialization of novel therapeutics, has appointed two new leaders to its executive team: Gregg Nyberg, Ph.D., as chief technology officer (CTO) and Michael Covington as chief quality and regulatory officer (CQRO).   Ran Zheng, chief executive officer of Landmark Bio said, “Bringing Michael and Gregg to the Landmark Bio executive team will further enable us to deliver on our mission to translate cutting-edge res...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters